Microglial proliferation can be induced by systemic delivery or direct injection of CSF1 into the hippocampus of mouse models used to investigate prion disease [22], Alzheimer’s disease [23], ischemic stroke [24], and amyotrophic lateral sclerosis [24]. This evidence concerns the gene CSF1 and early-onset autosomal dominant Alzheimer disease.